As a “deeply rooted” corporation, Bilim Pharmaceuticals, in line with its mission, attaches importance to people and human health; adopts quality as a philosophy of life; makes use of advanced technologies; performs production at international standards; develops economic products; and is customer-oriented and open to continuous development.

Founded in 1953, Bilim Pharmaceuticals is a 100% Turkish capital owned company that manufactures and markets drugs, a strategically important commodity. Ranked 3rd among 300 corporations in the Turkish pharmaceutical industry, Bilim Pharmaceuticals consistently continues to grow at a higher rate than the market. Bilim Pharmaceuticals carries out its production activities at two separate plants. Approved by the German Ministry of Health, Bilim Çerkezköy is one of Turkey’s most significant penicillin manufacturing facilities. Approved by the British Ministry of Health, Bilim Gebze is Turkey’s largest, most innovative and most environment-friendly drug manufacturing plant. Bilim Pharmaceuticals owns the largest R&D center of the Turkish pharmaceutical industry with a laboratory area of 4,500 square meters, where it develops new products, contributing significantly to the Turkish economy. Exporting to 50 countries, Bilim Pharmaceuticals has representative offices in Moldova, Georgia, Bosnia&Herzegovina and Albania. In a sensitive sector which is directly related to human health, Bilim Pharmaceuticals prioritizes quality and adopts respect towards future generations as a corporate value.


Steady and regular growth

      Bilim Pharmaceuticals provides “steady and regular growth” by being open to continuous development. In the Turkish pharmaceutical industry, that reached TL 14.4 billion in size in 2012, Bilim Pharmaceuticals ranked 3rd with a 4.9% market share. In terms of boxes sold to the market, Bilim Pharmaceuticals completed 2012 in 3rd place, selling 109.9 million boxes. Having completed the year in 2nd place in terms of physicians’ prescription preferences, Bilim Pharmaceuticals was preferred in 7,1 out of every 100 prescriptions. The company’s aim since its foundation was to be an effective player not only in Turkey but also in international markets; today Bilim Pharmaceuticals exports to 52 countries and plans to enter the American and European markets in the coming years.

Bilim Pharmaceuticals was one of the 5 companies to generate the highest turnover in three (antibiotics, respiratory system, muscular and skeletal system drugs) of the five segments, which account for the highest sales volume particularly in Turkey, while it owns 198 licensed drugs in the market.

Customer orientation

"Customer orientation" is a part of Bilim Pharmaceuticals' strategy of manufacturing and offering economic products and its principle of “respecting the community”. Carrying out its marketing and sales activities in 11 different locations throughout Turkey with 11 different teams and more than 1,200 field employees, the Bilim Pharmaceuticals team’s performance is evaluated every two years by means of customer satisfaction surveys and plans aiming to raise customer satisfaction are implemented. Having ranked among the top two companies in the Turkish pharmaceutical market and aiming to be the highest exporting local drug manufacturer by the end of 2014, Bilim Pharmaceuticals allocates nearly 5% of its budget to R&D investments.      

Importance attached to finding and developing new products

      Bilim Pharmaceuticals’ R&D Center is one of the largest R&D centers of the Turkish pharmaceutical industry with a total of 4,500 m2 in laboratory space. R&D center is equipped with state-of-the-art technology and carries out its efforts by means of technological and sensitive laboratory devices, with laboratory data automation and R&D pilot production facilities at FDA standards. Established with a $ 15 million investment, the R&D center boasts the largest R&D laboratory of the Turkish pharmaceutical industry. At the center, which employs 110 scientists, generic versions of original drugs, whose patents have expired, are prepared for offering to the market.

The center is equipped with 220 pieces of the state-of-the-art equipment.

Production Plants

Bilim Pharmaceuticals carries out its production activities at two separate plants in Çerkezköy and Gebze which are designed in accordance with cGMP (current good manufacturing practices). Approved by the German Ministry of Health, Bilim Çerkezköy Beta Lactam antibiotics production plant, which has an indoor area of 9,250 m2, has been in operation since 1998.      
      Having cost € 120 million, Bilim Gebze, with an indoor area of 51,500 m2, is the largest drug manufacturing plant in Turkey according to production forms. Accounting for 17% of the total production volume of the Turkish pharmaceutical industry with a manufacturing capacity of 250 million boxes per year, Bilim Gebze, as Turkey’s largest drug manufacturing plant and also one of Europe’s largest facilities, was designed and built according to American FDA standards.

Corporate responsibility awareness

Aware of its social, environmental and economic impacts, as well as its responsibilities towards its stakeholders, Bilim Pharmaceuticals believes in serving sustainability with an ethical, transparent and accountable corporate management approach as an indispensable part of its business approach and corporate culture.      


Bilim Pharmaceuticals’ Employees: A Part of the Solution

       Bilim Pharmaceuticals Community Volunteers is a platform which was established with the support of Bilim Pharmaceuticals in 2005 by voluntary employees, who share their individual competencies, intellectual knowledge, time, efforts and experiences with those in need “…in order to be a part of the solution”. As of 2011, the platform, with a total of 1,043 active members, operates in 11 cities throughout Turkey with 20 different teams.

Every year, volunteers prepare projects, and those that are approved by the higher board of team leaders are put in practice with the voluntary support of the families of Bilim Pharmaceuticals employees, as well as that of stakeholders. Volunteers have carried out a total of 248 events within the framework of 9 different projects and were able to reach more than 31,000 children and young people.

Pioneer in the Quality Journey

As the first national company to receive the “EFQM Competency Approval in Excellence” provided by the European Quality Association in 2004, Bilim Pharmaceuticals also received “The National Quality Grand Prize” in 2006 and “Award of Continuity in Excellence” (the most prestigious award given in Turkey to recognize efforts related to the Excellence Model) in 2010, which  are  handed out by  TÜSİAD  (The Turkish  Industrialists’ and Businessmen’s Association) and KalDer (Turkish Society for Quality).      

In 2011 Bilim Pharmaceuticals became the first company and the first pharmaceutical company to be deemed worthy of The Efqm Excellence Award, an award which no company in Europe has received for the last three years.  In addition to the Excellence Award, Bilim Pharmaceuticals was the first firm to be deemed worthy of the Achievement Prizes in four different categories.

These awards are the first and only awards ever obtained in the Turkish pharmaceutical sector. Acting upon the principle of conducting all of its operations by prioritizing “quality”, Bilim Pharmaceuticals has been performing its activities since 1998 within the framework of the EFQM Excellence Model, which is an institutionalization and management model aiming to satisfy all stakeholders. By doing so, the Company aims to yield results that please its shareholders, customers, employees and the community, and also aims to be a ”pioneer” in the quality journey and to play its role of offering guidance.